• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    52 Biggest Movers From Friday

    1/31/22 5:03:54 AM ET
    $AAPL
    $AFRM
    $AGTC
    $AHI
    Computer Manufacturing
    Technology
    Finance: Consumer Services
    Finance
    Get the next $AAPL alert in real time by email

    Gainers

    • Knightscope, Inc. (NASDAQ:KSCP) surged 175.6% to close at $3.40 on Friday. The company, on Thursday, priced its IPO at $10 per share.
    • Imperial Petroleum Inc. (NASDAQ:IMPP) shares climbed 87.9% to close at $2.18 on Friday. Imperial Petroleum, last month, posted Q3 revenue of $4.1 million.
    • Yoshitsu Co., Ltd (NASDAQ:TKLF) shares jumped 33.3% to settle at $3.40 after dropping 22% on Thursday.
    • Mawson Infrastructure Group, Inc. (NASDAQ:MIGI) gained 24.1% to close at $4.63 as stocks rebounded following recent weakness.
    • Dave Inc. (NASDAQ:DAVE) gained 23.7% to settle at $11.39.
    • Vaccinex, Inc. (NASDAQ:VCNX) shares climbed 23.5% to settle at $1.13 as the company announced private placement at $1.11 per share on Thursday.
    • Regencell Bioscience Holdings Limited (NASDAQ:RGC) surged 23.4% to close at $29.90.
    • Provention Bio, Inc. (NASDAQ:PRVB) shares gained 22.4% to close at $4.16 after the company announced its intent to resubmit the teplizumab BLA for the delay of clinical type 1 diabetes in at-risk individuals following its Type B pre-BLA resubmission meeting with the FDA.
    • Rallybio Corporation (NASDAQ:RLYB) gained 21.5% to settle at $12.02.
    • Applied Genetic Technologies Corporation (NASDAQ:AGTC) jumped 21% to close at $1.90. AGTC recently said it exceeded enrollment target in SKYLINE trial of AGTC-501 for the treatment of X-linked Retinitis Pigmentosa (XLRP).
    • Clearfield, Inc. (NASDAQ:CLFD) gained 19.8% to close at $58.28 after the company reported better-than-expected Q1 EPS and sales results.
    • FGI Industries Ltd. (NASDAQ:FGI) climbed 19.3% to close at $3.77 after declining over 15% on Thursday. The company recently priced its IPO at $6 per share.
    • Advanced Human Imaging Limited (NYSE:AHI) jumped 19.2% to settle at $2.17.
    • Park City Group, Inc. (NASDAQ:PCYG) gained 18.4% to close at $6.30.
    • Insulet Corporation (NASDAQ:PODD) gained 18.4% to close at $230.59 after the company announced FDA clearance of its Omnipod 5 Automated Insulin Delivery System.
    • TG Therapeutics, Inc. (NASDAQ:TGTX) jumped 17.7% to settle at $9.73. HC Wainwright & Co. maintained TG Therapeutics with a Buy and lowered the price target from $70 to $68.
    • Everspin Technologies, Inc.. (NASDAQ:MRAM) gained 17.2% to close at $9.35 after dropping 5% on Thursday.
    • Affirm Holdings, Inc. (NASDAQ:AFRM) jumped 17.1% to close at $59.71. DA Davidson upgraded the stock from Neutral to Buy, but lowered its price target on the stock from $110 to $75.
    • Ciner Resources LP (NYSE:CINR) climbed 16.8% to close at $19.05. Ciner Resources announced a quarterly distribution of $0.65 for the fourth quarter.
    • China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) jumped 16.8% to settle at $0.2177. China SXT Pharmaceuticals recently priced a $3.5 million underwritten public offering of ordinary shares.
    • Fair Isaac Corporation (NYSE:FICO) surged 16.6% to settle at $493.12 after the company reported better-than-expected Q1 EPS results.
    • Forte Biosciences, Inc. (NASDAQ:FBRX) jumped 16.7% to close at $1.54.
    • Calix, Inc. (NASDAQ:CALX) gained 15.8% to close at $46.80 after Craig-Hallum upgraded the stock from Hold to Buy and announced a $55 price target.
    • UserTesting, Inc. (NYSE:USER) rose 14.7% to close at $5.61.
    • Angion Biomedica Corp. (NASDAQ:ANGN) surged 14.3% to close at $2.48.
    • Novavax, Inc. (NASDAQ:NVAX) rose 13.7% to close at $82.92 after the company announced a supply agreement to provide an initial 5 million COVID-19 vaccine doses to Israel.
    • Fluidigm Corporation (NASDAQ:FLDM) surged 13.6% to settle at $3.18.
    • Braskem S.A. (NYSE:BAK) gained 11.1% to close at $18.96.
    • Visa Inc. (NYSE:V) jumped 10.6% to close at $228.00 after the company reported better-than-expected Q1 EPS and sales results.
    • Spectrum Pharmaceuticals, Inc.. (NASDAQ:SPPI) climbed 10.5% to close at $9.35 after dropping around 34% on Thursday.
    • Singularity Future Technology Ltd. (NASDAQ:SGLY) rose 10.4% to close at $3.93.
    • Apple Inc. (NASDAQ:AAPL) rose 7% to close at $170.33 after reporting upbeat quarterly results.
    • Calliditas Therapeutics AB (NASDAQ:CALT) gained 5.3% to close at $19.75 after the company reported commercial availability and initial sales of TARPEYO™.


    Check out these insider trading in big stocks

    Losers

    • Williams Industrial Services Group Inc. (NYSE:WLMS) shares fell 31.4% to close at $2.10 on Friday after the company issued weak sales forecast for FY22.
    • Volcon, Inc. (NASDAQ:VLCN) dipped 21.2% to close at $2.98. Volcon priced its underwritten public offering of 6.67 million shares of common stock at $3 per share.
    • InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) dropped 20.5% to close at $0.37.
    • DouYu International Holdings Limited (NASDAQ:DOYU) fell 19.1% to close at $2.04. DouYu International shares jumped 14% on Thursday after a Reuters report claimed the company will be taken private by Tencent.
    • MDJM Ltd (NASDAQ:MDJH) fell 15.8% to close at $1.5235.
    • Qurate Retail, Inc. (NASDAQ:QRTEA) fell 14.6% to close at $6.58. Qurate Retail said it sees preliminary Q4 retail revenue down 8% to 9%.
    • iClick Interactive Asia Group Limited (NASDAQ:ICLK) dipped 13% to close at $3.09. iClick recently appointed Mr. David Zhang as Chief Financial Officer and Board Director.
    • Kidpik Corp. (NASDAQ:PIK) dropped 12.6% to settle at $5.07.
    • ION Geophysical Corporation (NYSE:IO) fell 12.5% to close at $0.4465.
    • BT Brands, Inc. (NASDAQ:BTBD) shares fell 11.7% to close at $2.48.
    • Blue Star Foods Corp. (NASDAQ:BSFC) fell 11.2% to close at $2.39.
    • Bone Biologics Corporation (NASDAQ:BBLG) dropped 11.1% to close at $2.0623.
    • Movano Inc. (NASDAQ:MOVE) fell 9.5% to close at $2.39. Movano, on Thursday, announced three new US patents.
    • Cue Biopharma, Inc. (NASDAQ:CUE) dropped 9.5% to close at $7.23. Early data from a trial evaluating Cue Biopharma’s CUE-101 combined with Merck & Co’s Keytruda (pembrolizumab) demonstrated that two out of four patients in dose-escalation cohorts had partial responses.
    • Edgewise Therapeutics, Inc. (NASDAQ:EWTX) fell 8.5% to close at $12.60.
    • Sidus Space, Inc. (NYSE:SIDU) fell 8.5% to close at $9.88 after surging more than 31% on Thursday.
    • CITIC Capital Acquisition Corp. (NYSE:CCAC) fell 7.9% to close at $8.22.
    • Western Digital Corporation (NASDAQ:WDC) shares fell 7.3% to close at $49.90. Western Digital posted upbeat earnings and sales results for its second quarter, but issued a weak forecast. Western Digital named Wissam Jabre as its CFO.
    • V.F. Corporation (NYSE:VFC) dropped 6.5% to close at $62.96 following Q3 results.

    Also check out insider selling in big stocks

    Get the next $AAPL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAPL
    $AFRM
    $AGTC
    $AHI

    CompanyDatePrice TargetRatingAnalyst
    Apple Inc.
    $AAPL
    2/25/2026$241.00 → $270.00Neutral
    MoffettNathanson
    V.F. Corporation
    $VFC
    2/23/2026$18.00Neutral → Underweight
    Analyst
    Affirm Holdings Inc.
    $AFRM
    2/20/2026$55.00Neutral
    Robert W. Baird
    Fair Isaac Corporation
    $FICO
    2/17/2026$1900.00Buy
    BofA Securities
    Apple Inc.
    $AAPL
    2/10/2026$325.00 → $340.00Outperform
    Bernstein
    Dave Inc.
    $DAVE
    2/9/2026Outperform
    Keefe Bruyette
    Visa Inc.
    $V
    2/3/2026$370.00Neutral → Outperform
    Daiwa Securities
    Affirm Holdings Inc.
    $AFRM
    2/3/2026$76.00Equal-Weight → Overweight
    Morgan Stanley
    More analyst ratings

    $AAPL
    $AFRM
    $AGTC
    $AHI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for BRIUMVI issued to TG THERAPEUTICS, INC

    Submission status for TG THERAPEUTICS, INC's drug BRIUMVI (SUPPL-11) with active ingredient UBLITUXIMAB-XIIY has changed to 'Approval' on 10/30/2024. Application Category: BLA, Application Number: 761238, Application Classification:

    10/31/24 4:38:40 AM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    September 17, 2024 - FDA Roundup: September 17, 2024

    For Immediate Release: September 17, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued a draft guidance, “Integrating Randomized Controlled Trials for Drug and Biological Products into Routine Clinical Practice,” which, when finalized, will support the conduct of randomized controlled trials with streamlined protocols a

    9/17/24 2:34:22 PM ET
    $AAPL
    Computer Manufacturing
    Technology

    September 12, 2024 - FDA Authorizes First Over-the-Counter Hearing Aid Software

    For Immediate Release: September 12, 2024 Today, the U.S. Food and Drug Administration authorized the first over-the-counter (OTC) hearing aid software device, Hearing Aid Feature, intended to be used with compatible versions of the Apple AirPods Pro headphones. Once installed and customized to the user’s hearing needs, the Hearing Aid Feature enables compatible versions of the AirPods Pro to serve as an OTC hea

    9/12/24 10:58:17 AM ET
    $AAPL
    Computer Manufacturing
    Technology

    $AAPL
    $AFRM
    $AGTC
    $AHI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Minogue Michael R bought $499,847 worth of shares (2,030 units at $246.23) (SEC Form 4)

    4 - INSULET CORP (0001145197) (Issuer)

    2/26/26 7:05:23 AM ET
    $PODD
    Medical/Dental Instruments
    Health Care

    President and CEO Mcevoy Ashley bought $1,029,205 worth of shares (4,300 units at $239.35), increasing direct ownership by 45% to 13,916 units (SEC Form 4)

    4 - INSULET CORP (0001145197) (Issuer)

    2/23/26 8:14:32 AM ET
    $PODD
    Medical/Dental Instruments
    Health Care

    Large owner Endeavor Blockchain, Llc bought $192,502 worth of shares (42,100 units at $4.57), decreasing direct ownership by 100% to 4,397 units (SEC Form 4)

    4 - Mawson Infrastructure Group Inc. (0001218683) (Issuer)

    1/30/26 7:58:02 PM ET
    $MIGI
    Finance: Consumer Services
    Finance

    $AAPL
    $AFRM
    $AGTC
    $AHI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    MoffettNathanson reiterated coverage on Apple with a new price target

    MoffettNathanson reiterated coverage of Apple with a rating of Neutral and set a new price target of $270.00 from $241.00 previously

    2/25/26 10:07:53 AM ET
    $AAPL
    Computer Manufacturing
    Technology

    V.F. Corp downgraded by Analyst with a new price target

    Analyst downgraded V.F. Corp from Neutral to Underweight and set a new price target of $18.00

    2/23/26 8:34:02 AM ET
    $VFC
    Garments and Clothing
    Industrials

    Robert W. Baird initiated coverage on Affirm with a new price target

    Robert W. Baird initiated coverage of Affirm with a rating of Neutral and set a new price target of $55.00

    2/20/26 8:23:24 AM ET
    $AFRM
    Finance: Consumer Services
    Finance

    $AAPL
    $AFRM
    $AGTC
    $AHI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Wagner Susan

    4 - Apple Inc. (0000320193) (Issuer)

    2/26/26 6:34:19 PM ET
    $AAPL
    Computer Manufacturing
    Technology

    SEC Form 4 filed by Director Sugar Ronald D

    4 - Apple Inc. (0000320193) (Issuer)

    2/26/26 6:33:49 PM ET
    $AAPL
    Computer Manufacturing
    Technology

    SEC Form 4 filed by Director Lozano Monica C

    4 - Apple Inc. (0000320193) (Issuer)

    2/26/26 6:33:14 PM ET
    $AAPL
    Computer Manufacturing
    Technology

    $AAPL
    $AFRM
    $AGTC
    $AHI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Visa Completes Acquisition of Prisma and Newpay

    Visa (NYSE:V) today announced it has completed its acquisition of Prisma Medios de Pago S.A.U. ("Prisma") and Newpay S.A.U. ("Newpay") in Argentina. This transaction strengthens Visa's commitment to advancing payment innovation and modernizing financial infrastructure across the country. Prisma provides credit, debit and prepaid card issuer processing. Newpay is a multi-network infrastructure provider that operates real-time payments services, the Banelco ATM network and the bill payment platform PagoMisCuentas. Together, these companies provide compelling payments products and services serving millions of consumers and businesses throughout Argentina. "Today marks an exciting new chapt

    2/27/26 8:00:00 AM ET
    $V
    Real Estate

    Novavax to Participate in Upcoming Investor Conferences

    GAITHERSBURG, Md., Feb. 26, 2026 /PRNewswire/ -- Novavax, Inc. (NASDAQ:NVAX), today announced that it will participate in the following upcoming investor conferences:TD Cowen 46th Annual Health Care Conference:Fireside ChatDate:Tuesday, March 3, 2026Time:2:30 p.m. Eastern Time (ET)Location:Boston, MALeerink Partners 2026 Global Healthcare Conference:Fireside ChatDate:Tuesday, March 10, 2026Time:3:40 p.m. ETLocation:Miami Beach, FLJefferies Biotech on the Beach Summit:Investor MeetingsDate:Wednesday, March 11, 2026Location:Miami Beach, FLA webcast of the fireside chats will be available through the Events and Presentations page of the Company's website at ir.novavax.com. A replay of each webc

    2/26/26 4:30:00 PM ET
    $NVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Dave to Report Fourth Quarter and Full Year 2025 Results and Participate in Upcoming Investor Conferences

    LOS ANGELES, CA, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Dave Inc. ("Dave" or the "Company") (NASDAQ:DAVE), one of the nation's leading neobanks, today announced its participation in two upcoming investor conferences following the Company's fourth quarter and full year 2025 earnings conference call on Monday, March 2, 2026, at 5:00 p.m. Eastern time. The earnings conference call and investor conference details are as follows: Earnings Conference Call Date: Monday, March 2, 2026Time: 5:00 p.m. Eastern timeConference Call Registration: linkWebcast: link The conference call will also be available for replay in the Events section of the Company's website, along with the transcript, at https://in

    2/26/26 4:15:00 PM ET
    $DAVE
    Finance: Consumer Services
    Finance

    $AAPL
    $AFRM
    $AGTC
    $AHI
    SEC Filings

    View All

    Visa Inc. filed SEC Form 8-K: Other Events

    8-K - VISA INC. (0001403161) (Filer)

    2/27/26 4:06:59 PM ET
    $V
    Real Estate

    Clearfield Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Clearfield, Inc. (0000796505) (Filer)

    2/27/26 12:45:25 PM ET
    $CLFD
    Telecommunications Equipment
    Utilities

    Sidus Space Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement

    8-K - Sidus Space Inc. (0001879726) (Filer)

    2/26/26 4:30:49 PM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    $AAPL
    $AFRM
    $AGTC
    $AHI
    Leadership Updates

    Live Leadership Updates

    View All

    Sunbit Appoints Shachar G. Scott as Chief Marketing Officer to Accelerate its Next Phase of Growth

    Veteran global marketing leader joins from Meta as Sunbit scales products, partnerships and infrastructure to serve millions more consumers Sunbit, the personalized financial partner for everyday life, today announced the appointment of Shachar G. Scott as Chief Marketing Officer, signaling a pivotal next chapter in the company's growth. Scott brings more than 25 years of experience building and scaling global brands across technology and consumer products with leadership roles at Meta (NASDAQ:META), Apple (NASDAQ:AAPL), Bumble (NASDAQ:BMBL) and Snap (NYSE:SNAP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212757677/en/S

    2/12/26 10:14:00 AM ET
    $AAPL
    $BMBL
    $META
    Computer Manufacturing
    Technology
    Computer Software: Programming Data Processing

    Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Financial and Business Officer

    BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (NASDAQ:CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of autoimmune and inflammatory diseases, today announced that Lucinda Warren, who has served as Cue Biopharma's chief business officer (CBO) since September 2024, has been appointed chief financial and business officer (CFBO) effective February 9, 2026. "The combination of Lucinda's financial and business acumen together with her extensive background makes the CFBO a key strategic partner in helping drive business growth and Company success, part

    2/12/26 8:00:00 AM ET
    $CUE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dave Inc. Appoints Nima Khajehnouri to Board of Directors; Announces Board Leadership Transitions

    LOS ANGELES, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Dave Inc. ("Dave" or the "Company") (NASDAQ:DAVE), one of the nation's leading neobanks, today announced that Nima Khajehnouri, a distinguished leader in artificial intelligence and data engineering, has joined its Board of Directors, effective immediately. Mr. Khajehnouri will serve as a member of the Company's Audit Committee. Imran Khan, who has served on the Board since August 2023, is stepping down in conjunction with this appointment. Mr. Khajehnouri brings more than two decades' experience of leading engineering at some of the world's most influential technology companies. He currently serves as Vice President of Engineering at Meta, h

    1/20/26 5:27:46 PM ET
    $DAVE
    Finance: Consumer Services
    Finance

    $AAPL
    $AFRM
    $AGTC
    $AHI
    Financials

    Live finance-specific insights

    View All

    Dave to Report Fourth Quarter and Full Year 2025 Results and Participate in Upcoming Investor Conferences

    LOS ANGELES, CA, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Dave Inc. ("Dave" or the "Company") (NASDAQ:DAVE), one of the nation's leading neobanks, today announced its participation in two upcoming investor conferences following the Company's fourth quarter and full year 2025 earnings conference call on Monday, March 2, 2026, at 5:00 p.m. Eastern time. The earnings conference call and investor conference details are as follows: Earnings Conference Call Date: Monday, March 2, 2026Time: 5:00 p.m. Eastern timeConference Call Registration: linkWebcast: link The conference call will also be available for replay in the Events section of the Company's website, along with the transcript, at https://in

    2/26/26 4:15:00 PM ET
    $DAVE
    Finance: Consumer Services
    Finance

    Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

    Pfizer agreement announced in January 2026 for non-exclusive license to utilize Matrix-M® in two infectious disease areasMultiple Material Transfer Agreements signed in 2025 and Q1 2026 with pharmaceutical companies, including major global pharmaceutical companies exploring the utility of Matrix-M for their vaccine portfolios Successful execution of Sanofi partnership with $225 million in milestones earned in full year 2025Total revenue of $147 million in the fourth quarter of 2025 and $1.1 billion for the full year 2025Continued advancement of early-stage pipeline with the intention to enter the clinic as early as 2027Year end 2025 Cash of $751 million Novavax exceeded its full year 2025 R&

    2/26/26 8:00:00 AM ET
    $NVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    TG Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Raises BRIUMVI Revenue Guidance

    Fourth quarter and full year 2025 total revenue of $192.6 million and $616.3 million, including BRIUMVI U.S. net revenue of $182.7 million and $594.1 million, respectively Target guidance of approximately $875-900 million in total global revenue for 2026 Conference call to be held today, Thursday, February 26, 2026, at 8:30 AM ET NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX) (the Company or TG Therapeutics) today announced its financial results for the fourth quarter and full year ended December 31, 2025, along with recent company developments and 2026 financial guidance. Michael S. Weiss, the Company's Chairman and Chief Executive Off

    2/26/26 7:00:00 AM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAPL
    $AFRM
    $AGTC
    $AHI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by iClick Interactive Asia Group Limited

    SC 13D/A - iClick Interactive Asia Group Ltd (0001697818) (Subject)

    12/11/24 7:11:44 AM ET
    $ICLK
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Forte Biosciences Inc.

    SC 13G/A - Forte Biosciences, Inc. (0001419041) (Subject)

    12/6/24 4:05:50 PM ET
    $FBRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Vaccinex Inc.

    SC 13D/A - VACCINEX, INC. (0001205922) (Subject)

    11/18/24 4:15:28 PM ET
    $VCNX
    Biotechnology: Pharmaceutical Preparations
    Health Care